Welcome to LookChem.com Sign In|Join Free

CAS

  • or

15761-38-3

Post Buying Request

15761-38-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

15761-38-3 Usage

Chemical Properties

White to off-white microcrystalline powder

Uses

Boc-Ala-OH can be used: In the preparation of N-propargylalanine, a key precursor to generate N-(3-aryl)propylated alanine residues.In the resolution of racemic mixture of 3,3′-bis(benzyloxy)-1,1′-binaphthalene-2,2′-diol.In the one-pot synthesis of hybrid tripeptidomimetics containing both amide and imide functionalities.

Check Digit Verification of cas no

The CAS Registry Mumber 15761-38-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,5,7,6 and 1 respectively; the second part has 2 digits, 3 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 15761-38:
(7*1)+(6*5)+(5*7)+(4*6)+(3*1)+(2*3)+(1*8)=113
113 % 10 = 3
So 15761-38-3 is a valid CAS Registry Number.
InChI:InChI=1/C8H15NO4/c1-5(6(10)11)9-7(12)13-8(2,3)4/h5H,1-4H3,(H,9,12)(H,10,11)/p-1/t5-/m0/s1

15761-38-3 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (B1184)  N-(tert-Butoxycarbonyl)-L-alanine  >98.0%(HPLC)(T)

  • 15761-38-3

  • 5g

  • 140.00CNY

  • Detail
  • TCI America

  • (B1184)  N-(tert-Butoxycarbonyl)-L-alanine  >98.0%(HPLC)(T)

  • 15761-38-3

  • 25g

  • 410.00CNY

  • Detail
  • Alfa Aesar

  • (A16018)  N-Boc-L-alanine, 98+%   

  • 15761-38-3

  • 5g

  • 242.0CNY

  • Detail
  • Alfa Aesar

  • (A16018)  N-Boc-L-alanine, 98+%   

  • 15761-38-3

  • 25g

  • 910.0CNY

  • Detail
  • Aldrich

  • (15380)  Boc-Ala-OH  ≥99.0% (TLC)

  • 15761-38-3

  • 15380-5G

  • 313.56CNY

  • Detail
  • Aldrich

  • (15380)  Boc-Ala-OH  ≥99.0% (TLC)

  • 15761-38-3

  • 15380-25G

  • 1,248.39CNY

  • Detail
  • Aldrich

  • (15380)  Boc-Ala-OH  ≥99.0% (TLC)

  • 15761-38-3

  • 15380-100G

  • 2,607.93CNY

  • Detail

15761-38-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name N-(tert-Butoxycarbonyl)-L-alanine

1.2 Other means of identification

Product number -
Other names Boc-L-alanine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:15761-38-3 SDS

15761-38-3Synthetic route

(S)-N-(tert-butoxycarbonyl)alanine methyl ester
28875-17-4

(S)-N-(tert-butoxycarbonyl)alanine methyl ester

L-N-Boc-Ala
15761-38-3

L-N-Boc-Ala

Conditions
ConditionsYield
With 4-methyl-morpholine In water; acetonitrile at 30℃; under 7500600 Torr; for 96h;100%
With sodium hydroxide In acetone
L-alanin
56-41-7

L-alanin

di-tert-butyl dicarbonate
24424-99-5

di-tert-butyl dicarbonate

L-N-Boc-Ala
15761-38-3

L-N-Boc-Ala

Conditions
ConditionsYield
In 1,4-dioxane; water at 0 - 20℃; for 1h;100%
With sodium hydroxide In tetrahydrofuran; water at 20℃; for 17h;100%
With sodium hydroxide In tetrahydrofuran; water at 0 - 30℃; for 4.5h;98%
Boc-L-Ala-Pac-polystyrene resin

Boc-L-Ala-Pac-polystyrene resin

L-N-Boc-Ala
15761-38-3

L-N-Boc-Ala

Conditions
ConditionsYield
With bis(tri-n-butyltin)oxide In 1,2-dichloro-ethane at 83℃; for 25h;100%
N-Boc-Ala-Wang resin

N-Boc-Ala-Wang resin

L-N-Boc-Ala
15761-38-3

L-N-Boc-Ala

Conditions
ConditionsYield
With trimethyltin(IV) hydroxide In 1,2-dichloro-ethane for 9h; Heating;100%
tert-Butyl (2R,4S)-4-Methyl-5-oxo-2-phenyloxazolidine-3-carboxylate
139119-46-3

tert-Butyl (2R,4S)-4-Methyl-5-oxo-2-phenyloxazolidine-3-carboxylate

L-N-Boc-Ala
15761-38-3

L-N-Boc-Ala

Conditions
ConditionsYield
With lithium hydroxide In tetrahydrofuran; water at 0℃; for 0.333333h;97%
L-alanin
56-41-7

L-alanin

tert-butyl 2-oxo-1,3-oxazole-3(2H)-carboxylate
75844-68-7

tert-butyl 2-oxo-1,3-oxazole-3(2H)-carboxylate

L-N-Boc-Ala
15761-38-3

L-N-Boc-Ala

Conditions
ConditionsYield
With dmap In 1,4-dioxane; water Ambient temperature;96%
With dmap; triethylamine In 1,4-dioxane; water for 15h; Ambient temperature;96%
C22H25NO5

C22H25NO5

L-N-Boc-Ala
15761-38-3

L-N-Boc-Ala

Conditions
ConditionsYield
With potassium phosphate; tris(2,2-bipyridine)ruthenium(II) hexafluorophosphate; ascorbic acid In water; acetonitrile at 20℃; for 1h; Irradiation;96%
N-Boc-Ala-PAM resin

N-Boc-Ala-PAM resin

L-N-Boc-Ala
15761-38-3

L-N-Boc-Ala

Conditions
ConditionsYield
With trimethyltin(IV) hydroxide In 1,2-dichloro-ethane for 9h; Heating;94%
L-alanin
56-41-7

L-alanin

tert-butyl (2,4-dioxo-3-azaspiro[5,5]undecan-3-yl) carbonate

tert-butyl (2,4-dioxo-3-azaspiro[5,5]undecan-3-yl) carbonate

L-N-Boc-Ala
15761-38-3

L-N-Boc-Ala

Conditions
ConditionsYield
With sodium carbonate In water; acetonitrile at 25℃; for 10h;92%
2-tert-butoxycarbonylamino-propionic acid 3,3'-bis-benzyloxy-2'-(2-tert-butoxycarbonylamino-propionyloxy)-[1,1']binaphthalenyl-2-yl ester

2-tert-butoxycarbonylamino-propionic acid 3,3'-bis-benzyloxy-2'-(2-tert-butoxycarbonylamino-propionyloxy)-[1,1']binaphthalenyl-2-yl ester

A

L-N-Boc-Ala
15761-38-3

L-N-Boc-Ala

(S)‐3,3′‐bis(benzyloxy)‐[1,1′‐binaphthalene]‐2,2′‐diol

(S)‐3,3′‐bis(benzyloxy)‐[1,1′‐binaphthalene]‐2,2′‐diol

Conditions
ConditionsYield
With sodium hydroxide In tetrahydrofuran at 60℃; for 11h;A 79%
B 91%
L-alanin
56-41-7

L-alanin

1,2,2,2-Tetrachloroethyl tert-Butyl Carbonate
98015-52-2

1,2,2,2-Tetrachloroethyl tert-Butyl Carbonate

L-N-Boc-Ala
15761-38-3

L-N-Boc-Ala

Conditions
ConditionsYield
With triethylamine In 1,4-dioxane; water at 20℃; for 6h;90%
With triethylamine In 1,4-dioxane; water at 20℃; for 5h;90%
L-alanin
56-41-7

L-alanin

tert-butyl pyridin-2-yl carbonate
89985-91-1

tert-butyl pyridin-2-yl carbonate

A

2-hydroxypyridin
142-08-5

2-hydroxypyridin

B

L-N-Boc-Ala
15761-38-3

L-N-Boc-Ala

Conditions
ConditionsYield
With triethylamine In water; N,N-dimethyl-formamide for 8h; Ambient temperature;A n/a
B 90%
(2S,3S)-3-tert-butoxycarbonylamino-1,2-butanediol
154079-54-6

(2S,3S)-3-tert-butoxycarbonylamino-1,2-butanediol

L-N-Boc-Ala
15761-38-3

L-N-Boc-Ala

Conditions
ConditionsYield
With ruthenium trichloride; sodium periodate; sodium carbonate In tetrachloromethane; water; acetonitrile90%
BOC-Ala-OBg
119706-04-6

BOC-Ala-OBg

A

L-N-Boc-Ala
15761-38-3

L-N-Boc-Ala

B

N-Diphenylmethyl hydroxyacetamide
101089-89-8

N-Diphenylmethyl hydroxyacetamide

Conditions
ConditionsYield
With potassium carbonate In water; N,N-dimethyl-formamide for 0.5h; Ambient temperature;A 89%
B 87%
Boc-Ala-NHNHPh

Boc-Ala-NHNHPh

L-N-Boc-Ala
15761-38-3

L-N-Boc-Ala

Conditions
ConditionsYield
In acetonitrile for 216h; tyrosinase, phosphate buffer pH 7;89%
With phosphate buffer; tyrosinase In water; acetonitrile at 20℃; for 216h; pH=7.0;89%
L-alanin
56-41-7

L-alanin

(N-hydroxy-5-norbornene-2,3-diformylimino)tert-butyl ester
64205-15-8

(N-hydroxy-5-norbornene-2,3-diformylimino)tert-butyl ester

L-N-Boc-Ala
15761-38-3

L-N-Boc-Ala

Conditions
ConditionsYield
With tertiary amine In 1,4-dioxane; water for 3h;87%
(S)-2-tert-Butoxycarbonylamino-propionic acid 1-tert-butylcarbamoyl-2,2,2-trichloro-ethyl ester
78031-89-7

(S)-2-tert-Butoxycarbonylamino-propionic acid 1-tert-butylcarbamoyl-2,2,2-trichloro-ethyl ester

L-N-Boc-Ala
15761-38-3

L-N-Boc-Ala

Conditions
ConditionsYield
With sodium metaborate; cobalt(II) phthalocyanine In ethanol at 20℃; for 1.5h;87%
N-[(1,1-dimethylethoxy)carbonyl]-L-alanine 1,1-dimethylethyl ester
58177-77-8

N-[(1,1-dimethylethoxy)carbonyl]-L-alanine 1,1-dimethylethyl ester

L-N-Boc-Ala
15761-38-3

L-N-Boc-Ala

Conditions
ConditionsYield
With water; iodine In acetonitrile for 5h; Heating;86%
With cerium(III) chloride; sodium iodide In acetonitrile for 4h; Heating;75%
L-alanin
56-41-7

L-alanin

O-(tert-butyl) S-(pyridin-2-yl)carbonothioate
105678-24-8

O-(tert-butyl) S-(pyridin-2-yl)carbonothioate

A

2-Mercaptopyridine
2637-34-5

2-Mercaptopyridine

B

L-N-Boc-Ala
15761-38-3

L-N-Boc-Ala

Conditions
ConditionsYield
With triethylamine In water; N,N-dimethyl-formamide for 16h; Ambient temperature;A n/a
B 84%
L-alanin
56-41-7

L-alanin

dimethylsulfonium methylsulfate

dimethylsulfonium methylsulfate

L-N-Boc-Ala
15761-38-3

L-N-Boc-Ala

Conditions
ConditionsYield
With triethylamine In water Ambient temperature;82%
N-(tert-butyloxycarbonyl) azide
1070-19-5

N-(tert-butyloxycarbonyl) azide

L-alanin
56-41-7

L-alanin

L-N-Boc-Ala
15761-38-3

L-N-Boc-Ala

Conditions
ConditionsYield
With sodium hydroxide In 1,4-dioxane; water at 20℃; for 24h;78%
With triethylamine In 1,4-dioxane; water
L-alanin
56-41-7

L-alanin

2-t-butoxycarbonyloxy-3,6-diisopropylpyrazine
104272-92-6

2-t-butoxycarbonyloxy-3,6-diisopropylpyrazine

L-N-Boc-Ala
15761-38-3

L-N-Boc-Ala

Conditions
ConditionsYield
With triethylamine In water; acetonitrile for 24h; Ambient temperature;76%
(S)-tert-butyl (1-(bis(pyridin-2-ylmethyl)amino)-1-oxopropan-2-yl)carbamate
404566-47-8

(S)-tert-butyl (1-(bis(pyridin-2-ylmethyl)amino)-1-oxopropan-2-yl)carbamate

L-N-Boc-Ala
15761-38-3

L-N-Boc-Ala

Conditions
ConditionsYield
Stage #1: (S)-tert-butyl (1-(bis(pyridin-2-ylmethyl)amino)-1-oxopropan-2-yl)carbamate With methanol; copper(II) bis(trifluoromethanesulfonate) at 20℃; for 16h;
Stage #2: With barium(II) hydroxide In methanol; water at 20℃;
Stage #3: With citric acid In methanol; water pH=4 - 5;
76%
2-tert-butoxycarbonylamino-propionic acid 3,3'-bis-benzyloxy-2'-(2-tert-butoxycarbonylamino-propionyloxy)-[1,1']binaphthalenyl-2-yl ester

2-tert-butoxycarbonylamino-propionic acid 3,3'-bis-benzyloxy-2'-(2-tert-butoxycarbonylamino-propionyloxy)-[1,1']binaphthalenyl-2-yl ester

A

L-N-Boc-Ala
15761-38-3

L-N-Boc-Ala

(R)-3,3'-bis(benzyloxy)-1,1'-binaphthalene-2,2'-diol

(R)-3,3'-bis(benzyloxy)-1,1'-binaphthalene-2,2'-diol

Conditions
ConditionsYield
With sodium hydroxide In tetrahydrofuran at 60℃; for 11h;A 73%
B n/a
1-(4-methoxybenzyl)-(S)-2-(Boc-amino)propanoate

1-(4-methoxybenzyl)-(S)-2-(Boc-amino)propanoate

L-N-Boc-Ala
15761-38-3

L-N-Boc-Ala

Conditions
ConditionsYield
With zirconium(IV) chloride In acetonitrile at 20℃; for 1.5h;72%
L-alanin
56-41-7

L-alanin

2-(tert-Butoxycarbonyloxyimino)-2-phenylacetonitrile
58632-95-4

2-(tert-Butoxycarbonyloxyimino)-2-phenylacetonitrile

L-N-Boc-Ala
15761-38-3

L-N-Boc-Ala

Conditions
ConditionsYield
With triethylamine In 1,4-dioxane Ambient temperature;69%
With triethylamine In 1,4-dioxane; water for 4h; Ambient temperature;
L-alanin
56-41-7

L-alanin

t-butyl S-3,6-diisopropylpyrazin-2-ylthiolcarbonate
104272-95-9

t-butyl S-3,6-diisopropylpyrazin-2-ylthiolcarbonate

L-N-Boc-Ala
15761-38-3

L-N-Boc-Ala

Conditions
ConditionsYield
With dmap; triethylamine In water; acetonitrile for 24h; Ambient temperature;64%
N-Boc-L-alanine linked to Pam-resin

N-Boc-L-alanine linked to Pam-resin

L-N-Boc-Ala
15761-38-3

L-N-Boc-Ala

Conditions
ConditionsYield
With bis(tri-n-butyltin)oxide In chloroform at 61℃; for 96h;63%
(3S,5S,6R)-4-(tert-butyloxycarbonyl)-5,6-diphenyl-3-methyl-2,3,5,6-tetrahydro-4H-1,4-oxazin-2-one
123098-55-5

(3S,5S,6R)-4-(tert-butyloxycarbonyl)-5,6-diphenyl-3-methyl-2,3,5,6-tetrahydro-4H-1,4-oxazin-2-one

L-N-Boc-Ala
15761-38-3

L-N-Boc-Ala

Conditions
ConditionsYield
With ammonia; lithium In tetrahydrofuran; ethanol54%
With ethanol; ammonia; lithium In tetrahydrofuran at -33℃; for 1h;54%
L-N-Boc-Ala
15761-38-3

L-N-Boc-Ala

glycine ethyl ester hydrochloride
5680-79-5

glycine ethyl ester hydrochloride

methyl 2-((2S)-2-((tert-butoxycarbonyl)amino)propanamido)acetate
26061-06-3, 67706-13-2, 28369-58-6

methyl 2-((2S)-2-((tert-butoxycarbonyl)amino)propanamido)acetate

Conditions
ConditionsYield
With 4-methyl-morpholine; benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In N,N-dimethyl-formamide at 20℃;100%
With triethylamine In dichloromethane for 24h; Ambient temperature;91.3%
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine In dichloromethane at 0 - 20℃;85%
pyrrolidine
123-75-1

pyrrolidine

L-N-Boc-Ala
15761-38-3

L-N-Boc-Ala

(S)-(-)-N-(tert-butyloxycarbonyl)-N',N'-tetramethylenealaninamide
138356-92-0

(S)-(-)-N-(tert-butyloxycarbonyl)-N',N'-tetramethylenealaninamide

Conditions
ConditionsYield
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane for 4h; Ambient temperature;100%
With 1-(tert-butoxy)-2-(tert-butoxy)carbonyl-1,2-dihydroisoquinoline In dichloromethane at 20℃; for 5h;81%
Stage #1: L-N-Boc-Ala With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 0℃; for 0.5h;
Stage #2: pyrrolidine With 10-camphorsufonic acid In dichloromethane at 20℃; for 24h;
64%
L-N-Boc-Ala
15761-38-3

L-N-Boc-Ala

1-dodecyl alcohol
112-53-8

1-dodecyl alcohol

N-tert-butoxycarbonyl-L-alanine dodecyl ester
124212-36-8

N-tert-butoxycarbonyl-L-alanine dodecyl ester

Conditions
ConditionsYield
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 0 - 20℃;100%
papain on XAD-7 In dichloromethane at 37℃; for 18h;55%
L-N-Boc-Ala
15761-38-3

L-N-Boc-Ala

diazomethyl-trimethyl-silane
18107-18-1

diazomethyl-trimethyl-silane

(S)-N-(tert-butoxycarbonyl)alanine methyl ester
28875-17-4

(S)-N-(tert-butoxycarbonyl)alanine methyl ester

Conditions
ConditionsYield
In methanol; diethyl ether; benzene for 0.5h;100%
In methanol; hexane Ambient temperature;50%
In methanol; benzene
L-N-Boc-Ala
15761-38-3

L-N-Boc-Ala

glycine benzyl ester p-toluenesulfonic acid salt
1738-76-7

glycine benzyl ester p-toluenesulfonic acid salt

N-tert-butyloxycarbonyl-L-alanyl-glycine benzyl ester
23632-78-2

N-tert-butyloxycarbonyl-L-alanyl-glycine benzyl ester

Conditions
ConditionsYield
With benzotriazol-1-ol; N-(3-dimethylaminopropyl)-N-ethylcarbodiimide; triethylamine In N,N-dimethyl-formamide for 16h; Product distribution; Ambient temperature; effect of solvent, quality and quantity of additive, time of reaction; var. educts;100%
With benzotriazol-1-ol; N-(3-dimethylaminopropyl)-N-ethylcarbodiimide; triethylamine In N,N-dimethyl-formamide for 16h; Ambient temperature; equimolar educts and reagents;100%
With 4-methyl-morpholine; benzotriazol-1-ol; dicyclohexyl-carbodiimide In dichloromethane; N,N-dimethyl-formamide 1) 0 deg C, 8 h, 2) r.t., overnight;92%
L-N-Boc-Ala
15761-38-3

L-N-Boc-Ala

N,O-dimethylhydroxylamine*hydrochloride
6638-79-5

N,O-dimethylhydroxylamine*hydrochloride

tert-butyl {(S)-1-[methoxy(methyl)amino]-1-oxopropan-2-yl}carbamate
146553-06-2, 87694-49-3

tert-butyl {(S)-1-[methoxy(methyl)amino]-1-oxopropan-2-yl}carbamate

Conditions
ConditionsYield
With (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In dichloromethane100%
With (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃;100%
With 1,1'-carbonyldiimidazole In dichloromethane for 16h;99%
L-N-Boc-Ala
15761-38-3

L-N-Boc-Ala

(S)-2-[(S)-2-((S)-2-Amino-propionylamino)-3-methyl-butyrylamino]-6-benzyloxycarbonylamino-hexanoic acid pyridin-4-ylmethyl ester

(S)-2-[(S)-2-((S)-2-Amino-propionylamino)-3-methyl-butyrylamino]-6-benzyloxycarbonylamino-hexanoic acid pyridin-4-ylmethyl ester

Boc-Ala-Ala-Val-Lys(Z)-OPic
99461-56-0

Boc-Ala-Ala-Val-Lys(Z)-OPic

Conditions
ConditionsYield
With benzotriazol-1-ol; dicyclohexyl-carbodiimide100%
L-N-Boc-Ala
15761-38-3

L-N-Boc-Ala

(S)-2-Hydroxy-pentanedioic acid 1-tert-butyl ester 5-(4-nitro-benzyl) ester
55714-68-6

(S)-2-Hydroxy-pentanedioic acid 1-tert-butyl ester 5-(4-nitro-benzyl) ester

(S)-2-((S)-2-tert-Butoxycarbonylamino-propionyloxy)-pentanedioic acid 1-tert-butyl ester 5-(4-nitro-benzyl) ester

(S)-2-((S)-2-tert-Butoxycarbonylamino-propionyloxy)-pentanedioic acid 1-tert-butyl ester 5-(4-nitro-benzyl) ester

Conditions
ConditionsYield
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride100%
L-N-Boc-Ala
15761-38-3

L-N-Boc-Ala

L-alanin
56-41-7

L-alanin

Conditions
ConditionsYield
With water at 170℃; for 0.05h; Microwave irradiation;100%
With water at 150℃; for 2h; Subcritical conditions;100%
With tetradecyl(trihexyl)phosphonium bistriflamide; trifluoroacetic acid at 130℃; for 0.116667h; Ionic liquid;98%
L-N-Boc-Ala
15761-38-3

L-N-Boc-Ala

L-alanine N-carboxyanhydride
2224-52-4

L-alanine N-carboxyanhydride

Conditions
ConditionsYield
With phosphorus trichloride In dichloromethane at 0℃; for 2h;100%
With phosphorus trichloride In dichloromethane at 0℃; for 2h; Inert atmosphere;
L-N-Boc-Ala
15761-38-3

L-N-Boc-Ala

tert-butyldimethylsilyl chloride
18162-48-6

tert-butyldimethylsilyl chloride

C14H29NO4Si
130529-76-9

C14H29NO4Si

Conditions
ConditionsYield
With triethylamine In ethyl acetate at 0℃; for 0.5h;100%
L-N-Boc-Ala
15761-38-3

L-N-Boc-Ala

4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride
3945-69-5

4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride

2-tert-butoxycarbonylamino-propionic acid 4,6-dimethoxy-[1,3,5]triazin-2-yl ester

2-tert-butoxycarbonylamino-propionic acid 4,6-dimethoxy-[1,3,5]triazin-2-yl ester

Conditions
ConditionsYield
In 1,2-dimethoxyethane at 0℃; for 3h; Condensation;100%
L-N-Boc-Ala
15761-38-3

L-N-Boc-Ala

ethyl 2-(benzylamino)acetate
6436-90-4

ethyl 2-(benzylamino)acetate

Nα-Boc-Ala-Nα-benzylglycine ethyl ester
86666-85-5

Nα-Boc-Ala-Nα-benzylglycine ethyl ester

Conditions
ConditionsYield
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride Acylation;100%
With benzotriazol-1-ol; dicyclohexyl-carbodiimide In dichloromethane at 0 - 20℃; Condensation;93%
With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 20℃; for 24h;0.54 g
ethyl-2-thiourea
625-53-6

ethyl-2-thiourea

L-N-Boc-Ala
15761-38-3

L-N-Boc-Ala

Conditions
ConditionsYield
Multistep reaction;100%
4,6-O-di(tert-butyl)silanediyl-D-glucal
191593-14-3

4,6-O-di(tert-butyl)silanediyl-D-glucal

3-O-(N-tert-butoxycarbonyl-L-alanyl)-4,6-O-di-tert-butyl-silanediyl-D-arabino-hex-1-enitol

3-O-(N-tert-butoxycarbonyl-L-alanyl)-4,6-O-di-tert-butyl-silanediyl-D-arabino-hex-1-enitol

Conditions
ConditionsYield
With dmap; dicyclohexyl-carbodiimide In dichloromethane at 20℃; for 15h;100%
With dmap; dicyclohexyl-carbodiimide In dichloromethane
L-N-Boc-Ala
15761-38-3

L-N-Boc-Ala

1,5-anhydro-2-deoxy-4,6-O-di(tert-butyl)silanediyl-D-ribo-hex-1-enitol
578713-77-6

1,5-anhydro-2-deoxy-4,6-O-di(tert-butyl)silanediyl-D-ribo-hex-1-enitol

3-O-(N-tert-butoxycarbonyl-L-alanyl)-4,6-O-di-tert-butylsilanediyl-D-allal

3-O-(N-tert-butoxycarbonyl-L-alanyl)-4,6-O-di-tert-butylsilanediyl-D-allal

Conditions
ConditionsYield
With dmap; dicyclohexyl-carbodiimide In dichloromethane100%
L-N-Boc-Ala
15761-38-3

L-N-Boc-Ala

benzyl (2S)-2-pyrrolidinecarboxylate hydrochloride
16652-71-4

benzyl (2S)-2-pyrrolidinecarboxylate hydrochloride

N-t-butyloxycarbonyl-L-alanyl-L-proline benzyl ester
35084-69-6

N-t-butyloxycarbonyl-L-alanyl-L-proline benzyl ester

Conditions
ConditionsYield
With benzotriazol-1-ol; O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 0 - 20℃; for 18h; Inert atmosphere;100%
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In N,N-dimethyl-formamide at 20℃;88.2%
With N-ethyl-N,N-diisopropylamine In dichloromethane at 0 - 20℃; for 5h; Inert atmosphere;67%
L-N-Boc-Ala
15761-38-3

L-N-Boc-Ala

diallylamine
124-02-7

diallylamine

(S)-tert-butyl 1-(diallylamino)-1-oxopropan-2-ylcarbamate
950608-92-1

(S)-tert-butyl 1-(diallylamino)-1-oxopropan-2-ylcarbamate

Conditions
ConditionsYield
Stage #1: L-N-Boc-Ala With dicyclohexyl-carbodiimide In dichloromethane at 20℃; for 0.5h; Inert atmosphere;
Stage #2: diallylamine In dichloromethane at 20℃; for 12h; Inert atmosphere;
100%
With dicyclohexyl-carbodiimide In dichloromethane at 20℃; for 12h;
C46H45NO9Si

C46H45NO9Si

L-N-Boc-Ala
15761-38-3

L-N-Boc-Ala

C54H58N2O12Si

C54H58N2O12Si

Conditions
ConditionsYield
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 20℃; for 2h;100%
3-(benzofuran-7-yl)-4-(1-piperidin-4-yl-1H-indol-3-yl)pyrrole-2,5-dione hydrochloride

3-(benzofuran-7-yl)-4-(1-piperidin-4-yl-1H-indol-3-yl)pyrrole-2,5-dione hydrochloride

L-N-Boc-Ala
15761-38-3

L-N-Boc-Ala

3-(benzofur-7-yl)-4-{1-[1-[N-(tert-butoxycarbonyl)alanyl]piperidin-4-yl]indol-3-yl}pyrrole-2,5-dione

3-(benzofur-7-yl)-4-{1-[1-[N-(tert-butoxycarbonyl)alanyl]piperidin-4-yl]indol-3-yl}pyrrole-2,5-dione

Conditions
ConditionsYield
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine In DMF (N,N-dimethyl-formamide) at 20℃; for 3h;100%
L-N-Boc-Ala
15761-38-3

L-N-Boc-Ala

methylamine hydrochloride
593-51-1

methylamine hydrochloride

tert-butyl N-[(1S)-1-(methylcarbamoyl)ethyl]carbamate
84851-00-3

tert-butyl N-[(1S)-1-(methylcarbamoyl)ethyl]carbamate

Conditions
ConditionsYield
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine In N,N-dimethyl-formamide at 20℃; for 17.5h;100%
With O-(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate; N-ethyl-N,N-diisopropylamine In acetonitrile at 25℃; for 10h;68%
With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine In dichloromethane at 0 - 20℃;50%
With benzotriazol-1-ol; N-(3-dimethylaminopropyl)-N-ethylcarbodiimide; N-ethyl-N,N-diisopropylamine In dichloromethane at 23℃; for 12h;
With benzotriazol-1-ol; O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 0 - 20℃; for 2h;
L-N-Boc-Ala
15761-38-3

L-N-Boc-Ala

1-cyclopropyl-6-fluoro-7-[4-[2-fluoro-4-((R)-5-hydroxymethyl-2-oxo-oxazolidin-3-yl)-phenoxymethyl]-4-hydroxy-piperidin-1-yl]-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid benzyl ester
1025097-65-7

1-cyclopropyl-6-fluoro-7-[4-[2-fluoro-4-((R)-5-hydroxymethyl-2-oxo-oxazolidin-3-yl)-phenoxymethyl]-4-hydroxy-piperidin-1-yl]-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid benzyl ester

7-(4-{4-[(R)-5-((S)-2-tert-butoxycarbonylamino-propionyloxymethyl)-2-oxo-oxazolidin-3-yl]-2-fluoro-phenoxymethyl}-4-hydroxy-piperidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid benzyl ester
1025097-67-9

7-(4-{4-[(R)-5-((S)-2-tert-butoxycarbonylamino-propionyloxymethyl)-2-oxo-oxazolidin-3-yl]-2-fluoro-phenoxymethyl}-4-hydroxy-piperidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid benzyl ester

Conditions
ConditionsYield
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In N,N-dimethyl-formamide at 20℃; for 2h;100%
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In N,N-dimethyl-formamide at 20℃; for 2h;100%
(1R,4S,5S,6S)-4-amino-2,2-dioxo-2λ6-thia-bicyclo[3.1.0]hexane-4,6-dicarboxylic acid diethyl ester
635317-59-8

(1R,4S,5S,6S)-4-amino-2,2-dioxo-2λ6-thia-bicyclo[3.1.0]hexane-4,6-dicarboxylic acid diethyl ester

L-N-Boc-Ala
15761-38-3

L-N-Boc-Ala

(1R,4S,5S,6S)-4-(2'S-tert-butoxycarbonylaminopropylamino)-2,2-dioxo-2λ6-thia-bicyclo[3.1.0]hexane-4,6-dicarboxylic acid diethyl ester
635317-60-1

(1R,4S,5S,6S)-4-(2'S-tert-butoxycarbonylaminopropylamino)-2,2-dioxo-2λ6-thia-bicyclo[3.1.0]hexane-4,6-dicarboxylic acid diethyl ester

Conditions
ConditionsYield
Stage #1: L-N-Boc-Ala With 4-methyl-morpholine; isobutyl chloroformate In dichloromethane at -30 - -25℃; for 0.666667h;
Stage #2: (1R,4S,5S,6S)-4-amino-2,2-dioxo-2λ6-thia-bicyclo[3.1.0]hexane-4,6-dicarboxylic acid diethyl ester In dichloromethane at -25 - 19℃; for 1.41667h;
100%
L-N-Boc-Ala
15761-38-3

L-N-Boc-Ala

(2S,3E)-4-(4-bromophenyl)-3-buten-2-ol
690257-96-6

(2S,3E)-4-(4-bromophenyl)-3-buten-2-ol

(S)-[(S,E)-4-(4-bromophenyl)but-3-en-2-yl] 2-(tert-butoxycarbonylamino)propanoate
1174006-17-7

(S)-[(S,E)-4-(4-bromophenyl)but-3-en-2-yl] 2-(tert-butoxycarbonylamino)propanoate

Conditions
ConditionsYield
With dmap; dicyclohexyl-carbodiimide In diethyl ether at 0 - 20℃; Inert atmosphere;100%
L-N-Boc-Ala
15761-38-3

L-N-Boc-Ala

C9H20N2O3

C9H20N2O3

C17H31N3O6
1209481-66-2

C17H31N3O6

Conditions
ConditionsYield
With O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 0℃; for 1.5h; Inert atmosphere;100%
L-N-Boc-Ala
15761-38-3

L-N-Boc-Ala

L-valine benzyl ester p-toluenesulfonate salt
16652-76-9

L-valine benzyl ester p-toluenesulfonate salt

Boc-L-Ala-L-Val-OBzl
116798-35-7

Boc-L-Ala-L-Val-OBzl

Conditions
ConditionsYield
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine100%

15761-38-3Relevant articles and documents

Optically active helical substituted polyacetylenes as chiral seeding for inducing enantioselective crystallization of racemic N -(tert -butoxycarbonyl)alanine

Chen, Bo,Deng, Jianping,Cui, Xin,Yang, Wantai

, p. 7109 - 7114 (2011)

Helical substituted polyacetylenes were investigated for inducing enantioselective crystallization of racemic N-(tert-butoxycarbonyl)alanine (BOC-alanine) enantiomers. For this purpose, helical substituted polyacetylenes [(R)-PSA and (S)-PSA)] were dissolved in supersaturated racemic BOC-alanine solutions. Upon cooling the solutions, (R)-PSA preferentially induced BOC-l-alanine to crystallize, while (S)-PSA facilitated the enantioselective crystallization of BOC-d-alanine, according to the characterizations by circular dichroism, XRD, SEM, and optical rotation analyses. As expected, no enantioselective crystallization was observed in such cases: racemic BOC-alanine enantiomers in the absence of optically active helical PSA and racemic BOC-alanine enantiomers in the presence of equal amount of (R)-PSA and (S)-PSA. The present study provides the first direct evidence for the role of artificially synthetic helical polymers in inducing efficiently enantioselective crystallization.

Synthesis and biological properties of enkephalin-like peptides containing carboranylalanine in place of phenylalanine

Schwyzer,Do,Eberle,Fauchere

, p. 2078 - 2083 (1981)

-

Copolymerization of chiral amino acid-based acetylenes and helical conformation of the copolymers

Gao, Guangzheng,Sanda, Fumio,Masuda, Toshio

, p. 3938 - 3943 (2003)

The present study deals with the copolymerization of an amino acid-based acetylene, N-(tert-butoxycarbonyl)-L-alanine N′-propargylamide (L-1A) with the optical isomer (D-1A), achiral hexanoic acid N-propargylamide (2A), and pivalic acid N-propargylamide (3A), and chiroptical properties of the copolymers. The copolymerization catalyzed by (nbd)Rh+[η6-C6H5B- (C6H5)3] afforded copolymers with number-average molecular weights over 104 in good yields. Nonlinear relationships were observed in the specific rotation and CD and UV-vis spectroscopies with respect to the L-1A content in feed. For instance, poly(L-1A-co-D-1A)s incorporated with 12.5% of either optical isomer (75% ee) exhibited almost the same optical properties as those of the homopolymers. Chiral amplification was observed in the copolymerization of L-1A with the achiral monomers. The specific rotation of poly(L-1A-co-2A) with 45% L-1A unit was practically the same as that of poly(L-1A). The copolymers of L-1A and 3A with an L-1A content in feed as low as 12% exhibited nearly the same helix content as the homopolymer of L-1A did.

Efficient, non-acidolytic method for the selective cleavage of N-Boc amino acid and peptide phenacyl esters linked to a polystyrene resin

Furlan, Ricardo L. E.,Mata, Ernesto G.,Mascaretti, Oreste A.

, p. 355 - 358 (1998)

An efficient, non-acidolytic method for the selective cleavage of phenacyl esters of N-Boc-amino acids and -peptides linked to a polystyrene resin by (CH3)3SnOH (TMTOH) or [(n-C4H9)3Sn]2O (BBTO) is described. We highly recommend the use of trimethyltin hydroxide for the selective cleavage of carboxylic esters based on its favourable properties. The method is compatible with an N-Boc/O-Bn (benzyl ether) strategy and yields enantiomerically pure N-Boc-peptides useful for further manipulation, for segment condensations or for cyclization strategies. A mechanism for the cleavage of methyl phenylacetate in solution by TMTOH is postulated.

Biocatalytic resolution of Boc-dl-alanine methyl ester by a newly isolated Bacillus amyloliquefaciens WZZ002

Zheng, Jian-Yong,Wang, Yu-Qiang,Luo, Wei-Feng,Zhou, Sha-Sha,Zhu, Qing,Ying, Xiang-Xian,Wang, Zhao

, p. 134 - 137 (2014)

A new esterase-producing strain (Bacillus amyloliquefaciens WZZ002) that exhibits high hydrolytic activity, excellent enantioselectivity, and high substrate tolerance on Boc-dl-Alanine methyl ester was isolated from soil samples. The reaction temperature, pH, and neutralizer optima of the cell-mediated biocatalysis were 35 °C, pH 8.0, and NH3·H2O, respectively. The optimal substrate concentration was 2 M, with a biocatalyst loading of 50 g/L. Results showed that the enantiomeric excess values of substrate and product were both greater than 99%. Thus, bioprocessing with the use of the isolated strain is a promising route for the commercial production of Boc-d-Ala-OMe.

Self-assembly of β-turn forming synthetic tripeptides into supramolecular β-sheets and amyloid-like fibrils in the solid state

Maji, Samir Kumar,Haldar, Debasish,Drew, Michael G. B.,Banerjee, Arijit,Das, Apurba Kumar,Banerjee, Arindam

, p. 3251 - 3259 (2004)

We have described here the self-assembling properties of the synthetic tripeptides Boc-Ala(1)-Aib(2)-Val(3)-OMe 1, Boc-Ala(1)-Aib(2)-Ile(3)-OMe 2 and Boc-Ala(1)-Gly(2)-Val(3)-OMe 3 (Aib=α-amino isobutyric acid, β-Ala=β-alanine) which have distorted β-turn conformations in their respective crystals. These turn-forming tripeptides self-assemble to form supramolecular β-sheet structures through intermolecular hydrogen bonding and other noncovalent interactions. The scanning electron micrographs of these peptides revealed that these compounds form amyloid-like fibrils, the causative factor for many neurodegenerative diseases including Alzheimer's disease, Huntington's disease and Prion-related encephalopathies.

Enantioselective hydrolysis of amino acid esters by non-chiral copper complexes equipped with bis (β-cyclodextrin)s

Xue, Shan-Shan,Zhao, Meng,Lan, Jing-Xing,Ye, Rui-Rong,Li, Yi,Ji, Liang-Nian,Mao, Zong-Wan

, p. 297 - 303 (2016)

Two non-chiral copper(II) complexes equipped with bis(β-cyclodextrin)s (bisCDs) were explored as hydrolase models for the enantioselective hydrolysis of two pairs of alkyl chain-possessing amino acid ester enantiomers. The two bisCD complexes are pyridine-linked with different CD cavity orientations, denoted as CuL1 (L1?=?2,6-bis(6-mono-amino-β-cyclodextrin-methyl)-pyridine) and CuL2 (L2?=?2,6-bis(3-mono-amino-β-cyclodextrin-methyl)-pyridine). Kinetic studies indicated that the “back-to-back” bisCD complex CuL1 showed higher catalytic efficiency and more pronounced enantioselectivity for all substrates than the “face-to-face” bisCD complex CuL2. Overall preference of L-isomers was observed for both complexes. In the presence of CuL1, the formation of catalyst-substrate Michaelis complexes during the hydrolysis was demonstrated by saturation kinetic study and Electrospray ionization mass spectrometry (ESI–MS) analysis. Enantiomer selectivity (vmaxL/vmaxD) value for N-Boc-N'-Boc-Lysine 4-nitrophenyl esters (Boc-Lys(Boc)-ONp), the longer alkyl-chain analogs, is twice of that for N-Boc-Alanine 4-nitrophenyl esters (Boc-Ala-ONp). The enantioselective hydrolysis of Boc-Lys(Boc)-ONp promoted by CuL1 was confirmed by chiral high-performance liquid chromatography (HPLC) analysis. The participation of CD cavities during enantioselective hydrolysis was investigated through inhibition assay. The enantioselectivity in hydrolyzing different amino acid esters promoted by CuL1 was compared. The mechanism involved in the cooperation of two adjacent CD cavities of bisCD was proposed.

Monofunctional platinum complexes showing potent cytotoxicity against human liver carcinoma cell line BEL-7402

Zhang, Junyong,Wang, Xiaoyong,Tu, Chao,Lin, Jun,Ding, Jian,Lin, Liping,Wang, Zheming,He, Cheng,Yan, Chunhua,You, Xiaozeng,Guo, Zijian

, p. 3502 - 3507 (2003)

Three novel Pt(II) complexes [PtL1′Cl] I (L1′ = glycine-N′-8-quinolylamide), [PtL2′Cl] II (L2′= L-alanine-N′-8-quinolylamide), and [PtL3Cl] III [L3 = N-(tert-butoxycarbonyl)-L-methionine-N′-8-quinolylamide] have been synthesized and characterized. The crystal structure of complexes II and III showed that the ligands are three-coordinated with only one Cl- as the leaving group. Complex II crystallized in the monoclinic system with space group P2(1), a = 9.502(2) ?, b = 4.724(1) ?, c = 14.800(3) ?, while complex III crystallized in the orthorhombic system with space group P2(1)2(1)2(1), a = 5.441(1) ?, b = 12.978(3) ?, c = 29.438(6) ?. These complexes have been tested against a wide range of tumor cell lines including BEL-7402, HCT-116, SPC-A4, MOLT-4, P388, HL-60, A-549, SGC-7901, MKN-28, and HO-8910. Complex III is highly cytotoxic against the HCT-116 (IC50 = 0.38 μM), SPC-A4 (IC50 = 0.43 μM), BEL-7402 (IC50 = 0.43 μM), and MOLT-4 (IC50 = 0.61 μM) cell lines. The cell line most sensitive to III is human liver carcinoma cell line BEL-7402, which has a response rate of 75.1% at 6.6 × 10-7 M, nearly 6 times higher than that of cisplatin.

Membrane transport inspired hydrolysis of non-activated esters at near physiological pH

Mandal, Raki,Mahanty, Kingshuk,Mandal, Subhendu,De Sarkar, Suman,Tarafdar, Pradip K.

supporting information, p. 11088 - 11091 (2021/10/30)

A positively charged micelle loaded with substrates was transported selectively to the reaction site (cathode) to promote the proximity and localization of the reactants (ester and hydroxide). The guided vehicular delivery coupled with electrolysis allows the hydrolysis of non-activated esters at near physiological pH with significant yields along with recyclability.

Design, synthesis, and biological evaluation of novel Bcr-AblT315I inhibitors incorporating amino acids as flexible linker

Li, Yanchen,Li, Zilong,Liu, Nanxin,Pan, Xiaoyan,Shan, YuanYuan,Wang, Kai,Zhang, Jie,Zhang, Qingqing

, (2021/09/22)

Despite the success of imatinib in CML therapy through Bcr-Abl inhibition, acquired drug resistance occurs over time in patients. In particular, the resistance caused by T315I mutation remains a challenge in clinic. Herein, we embarked on a structural optimization campaign aiming at discovery of novel Bcr-Abl inhibitors toward T315I mutant based on previously reported dibenzoylpiperazin derivatives. We proposed that incorporation of flexible linker could achieve potent inhibition of Bcr-AblT315I by avoiding steric clash with bulky sidechain of Ile315. A library of 28 compounds with amino acids as linker has been developed and evaluated. Among them, compound AA2 displayed the most potent activity against Bcr-AblWT and Bcr-AblT315I, as well as toward Bcr-Abl driven K562 and K562R cells. Further investigations indicated that AA2 could induce apoptosis of K562 cells and down regulate phosphorylation of Bcr-Abl. In summary, the compounds with amino acid as novel flexible linker exhibited certain antitumor activities, providing valuable hints for the discovery of novel Bcr-Abl inhibitors to overcome T315I mutant resistance, and AA2 could be considered as a candidate for further optimization.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 15761-38-3